Success Metrics

Clinical Success Rate
88.5%

Based on 23 completed trials

Completion Rate
88%(23/26)
Active Trials
19(30%)
Results Posted
17%(4 trials)
Terminated
3(5%)

Phase Distribution

Ph not_applicable
21
33%
Ph phase_1
2
3%
Ph phase_4
2
3%
Ph phase_2
1
2%
Ph phase_3
1
2%

Phase Distribution

2

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution27 total trials
Phase 1Safety & dosage
2(7.4%)
Phase 2Efficacy & side effects
1(3.7%)
Phase 3Large-scale testing
1(3.7%)
Phase 4Post-market surveillance
2(7.4%)
N/ANon-phased studies
21(77.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.7%

23 of 30 finished

Non-Completion Rate

23.3%

7 ended early

Currently Active

19

trials recruiting

Total Trials

63

all time

Status Distribution
Active(22)
Completed(23)
Terminated(7)
Other(11)

Detailed Status

Completed23
Recruiting16
unknown11
Withdrawn4
Active, not recruiting3
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
63
Active
19
Success Rate
88.5%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (7.4%)
Phase 21 (3.7%)
Phase 31 (3.7%)
Phase 42 (7.4%)
N/A21 (77.8%)

Trials by Status

recruiting1625%
active_not_recruiting35%
terminated35%
completed2337%
withdrawn46%
unknown1117%
not_yet_recruiting35%

Recent Activity

19 active trials
Showing 5 of 63
not_yet_recruiting

Hepatic Lipid Metabolism-Alcohol Use Disorder

NCT07191561
recruiting

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

NCT05623150
active_not_recruitingnot_applicable

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population

NCT06218589
not_yet_recruiting

Liver Biopsy Following Gene Therapy For Hemophilia

NCT05932914
recruiting

Early Detection of Liver Cancer by QUS

NCT06345508
View all 63 trials

Clinical Trials (63)

Showing 20 of 63 trialsScroll for more
NCT07191561

Hepatic Lipid Metabolism-Alcohol Use Disorder

Not Yet Recruiting
NCT05623150

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

Recruiting
NCT06218589Not Applicable

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population

Active Not Recruiting
NCT05932914

Liver Biopsy Following Gene Therapy For Hemophilia

Not Yet Recruiting
NCT06345508

Early Detection of Liver Cancer by QUS

Recruiting
NCT06779058

MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B

Recruiting
NCT04365855Not Applicable

The Olmsted NAFLD Epidemiology Study (TONES)

Recruiting
NCT06797193Not Applicable

Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension

Recruiting
NCT06470997

Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors

Recruiting
NCT03193151

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

Recruiting
NCT03694691Not Applicable

Developing Viability Index for Machine Perfused Livers

Recruiting
NCT06592820

Endoscopic Ultrasound Shear Wave Elastography Study

Recruiting
NCT05499949

The Franciscus Obesity NASH Study

Active Not Recruiting
NCT02995252

The HOPE Study: Characterizing Patients With Hepatitis B and C

Recruiting
NCT02206841

Establishment of NAFLD Cohort and Development of Fibrosis Markers

Recruiting
NCT04817462Not Applicable

Liver Biopsy In Haemophilia Gene Therapy

Recruiting
NCT06628726Not Applicable

Liver Biopsy in Diagnosis Neonatal Jaundice

Not Yet Recruiting
NCT03674528

Technical Validation of MR Biomarkers of Obesity-Associated NAFLD

Completed
NCT06499675

Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery; a Biopsy-based Study

Completed
NCT06355700Not Applicable

Hepatocellular Carcinoma Liver Organoids

Recruiting

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
63